Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890951284> ?p ?o ?g. }
- W2890951284 endingPage "347" @default.
- W2890951284 startingPage "347" @default.
- W2890951284 abstract "The nucleus accumbens-associated protein 1 (NACC1) is a transcription factor constitutively expressed in the urothelium, where it regulates cell growth, senescence, autophagy, and epithelial-mesenchymal transition. microRNA (miRNA) constitutes a class of small non-coding RNAs which are involved in cell proliferation, differentiation, and progression of tumors. miRNAs and their target molecules are utilized for molecular diagnosis of urothelial carcinoma. NACC1 is one of several putative target molecules of miR-331-3p, and is associated with cell proliferation in cancers such as prostate and cervical cancer. Functional experiments involving miR-331-3p and its target molecule NACC1 were conducted using the urothelial carcinoma (UC) cell lines, T24, UMUC6, and KU7. Furthermore, quantitative reverse transcription polymerase chain reaction and immunostaining were performed to evaluate the expression of NACC1 in UC derived from transurethral resection of bladder tumor (TUR-Bt) specimens. The methane thiosulfonate (MTS) assay revealed that cell proliferation was significantly reduced after transient transfection of miR-331-3p precursor and/or NACC1 siRNA in UC cells. Cell senescence via cell cycle arrest at the G1 phase was induced by NACC1 inhibition. On the other hand, suppression of NACC1 induced cell migration and invasion abilities. Immunohistochemical analysis of TUR-Bt specimens revealed that over 70% of UC cells presented strongly positive results for NACC1. In contrast, normal urothelial cells were weakly positive for NACC1. It was also found that NACC1 expression was lower in invasive UC cells than in non-invasive UC cells. Loss of NACC1 induced vessel invasion in invasive UC tissues. The present results indicate that NACC1 regulated by miR-331-3p contributes to cell proliferation, and is involved in cell migration and invasion. This suggests that NACC1 can serve as a potential target molecule for the prediction and prognosis of UC, and can contribute to effective treatment strategies." @default.
- W2890951284 created "2018-09-27" @default.
- W2890951284 creator A5006288077 @default.
- W2890951284 creator A5017624165 @default.
- W2890951284 creator A5019242250 @default.
- W2890951284 creator A5023252008 @default.
- W2890951284 creator A5044933503 @default.
- W2890951284 creator A5048998910 @default.
- W2890951284 creator A5049550200 @default.
- W2890951284 creator A5050544002 @default.
- W2890951284 creator A5053890395 @default.
- W2890951284 creator A5056692031 @default.
- W2890951284 creator A5061863751 @default.
- W2890951284 creator A5062816796 @default.
- W2890951284 creator A5071529858 @default.
- W2890951284 creator A5085943256 @default.
- W2890951284 date "2018-09-21" @default.
- W2890951284 modified "2023-09-27" @default.
- W2890951284 title "NACC1, as a Target of MicroRNA-331-3p, Regulates Cell Proliferation in Urothelial Carcinoma Cells" @default.
- W2890951284 cites W1490889718 @default.
- W2890951284 cites W1561990757 @default.
- W2890951284 cites W1963679257 @default.
- W2890951284 cites W1970993743 @default.
- W2890951284 cites W1976457549 @default.
- W2890951284 cites W1982502197 @default.
- W2890951284 cites W1988028469 @default.
- W2890951284 cites W1991327249 @default.
- W2890951284 cites W2005453082 @default.
- W2890951284 cites W2012684528 @default.
- W2890951284 cites W2017425012 @default.
- W2890951284 cites W2027239626 @default.
- W2890951284 cites W2027450688 @default.
- W2890951284 cites W2039164708 @default.
- W2890951284 cites W2057689789 @default.
- W2890951284 cites W2060257345 @default.
- W2890951284 cites W2084810520 @default.
- W2890951284 cites W2095607019 @default.
- W2890951284 cites W2103762288 @default.
- W2890951284 cites W2108596041 @default.
- W2890951284 cites W2112251761 @default.
- W2890951284 cites W2118581504 @default.
- W2890951284 cites W2118680637 @default.
- W2890951284 cites W2119642227 @default.
- W2890951284 cites W2121107160 @default.
- W2890951284 cites W2137206967 @default.
- W2890951284 cites W2139365743 @default.
- W2890951284 cites W2148448730 @default.
- W2890951284 cites W2150891811 @default.
- W2890951284 cites W2163562805 @default.
- W2890951284 cites W2167849637 @default.
- W2890951284 cites W2171917937 @default.
- W2890951284 cites W2263128928 @default.
- W2890951284 cites W2399259556 @default.
- W2890951284 cites W2401722553 @default.
- W2890951284 cites W2462851203 @default.
- W2890951284 cites W2509821720 @default.
- W2890951284 cites W2609441489 @default.
- W2890951284 cites W2728049441 @default.
- W2890951284 cites W2735269733 @default.
- W2890951284 cites W2743896592 @default.
- W2890951284 cites W2752279058 @default.
- W2890951284 cites W2764186392 @default.
- W2890951284 cites W2773233196 @default.
- W2890951284 cites W2774536022 @default.
- W2890951284 cites W2915478882 @default.
- W2890951284 cites W573831242 @default.
- W2890951284 cites W884353920 @default.
- W2890951284 doi "https://doi.org/10.3390/cancers10100347" @default.
- W2890951284 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6210667" @default.
- W2890951284 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30248959" @default.
- W2890951284 hasPublicationYear "2018" @default.
- W2890951284 type Work @default.
- W2890951284 sameAs 2890951284 @default.
- W2890951284 citedByCount "19" @default.
- W2890951284 countsByYear W28909512842019 @default.
- W2890951284 countsByYear W28909512842020 @default.
- W2890951284 countsByYear W28909512842021 @default.
- W2890951284 countsByYear W28909512842022 @default.
- W2890951284 countsByYear W28909512842023 @default.
- W2890951284 crossrefType "journal-article" @default.
- W2890951284 hasAuthorship W2890951284A5006288077 @default.
- W2890951284 hasAuthorship W2890951284A5017624165 @default.
- W2890951284 hasAuthorship W2890951284A5019242250 @default.
- W2890951284 hasAuthorship W2890951284A5023252008 @default.
- W2890951284 hasAuthorship W2890951284A5044933503 @default.
- W2890951284 hasAuthorship W2890951284A5048998910 @default.
- W2890951284 hasAuthorship W2890951284A5049550200 @default.
- W2890951284 hasAuthorship W2890951284A5050544002 @default.
- W2890951284 hasAuthorship W2890951284A5053890395 @default.
- W2890951284 hasAuthorship W2890951284A5056692031 @default.
- W2890951284 hasAuthorship W2890951284A5061863751 @default.
- W2890951284 hasAuthorship W2890951284A5062816796 @default.
- W2890951284 hasAuthorship W2890951284A5071529858 @default.
- W2890951284 hasAuthorship W2890951284A5085943256 @default.
- W2890951284 hasBestOaLocation W28909512841 @default.
- W2890951284 hasConcept C104317684 @default.
- W2890951284 hasConcept C134018914 @default.
- W2890951284 hasConcept C145059251 @default.